CRSP
#1360
CRISPR Therapeutics AG - Common Shares
50.6 3 USD
-0.05%
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
-5.10%
Monthly Change
-0.73%
6 month change
-11.03%
Year Change
-10.23%
Previous Close
53.3 5
Open
50.6 3
Low
50.6 3
High
50.6 3
Volume
114
Financials
- Market Capitalization 4.88 B
- Employee 393
- Founded 2013
- CEO Samarth Kulkarni
- Website www.crisprtx.com
- Headquarter Switzerland
- FIGI UNKNOWN
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-7.71
Price to sales ratio
1 062.57
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 1301 |  TVTX Travere Therapeutics, Inc. - Common Stock | 56.29 USD | -0.53% | -2.58% | +6.63% | +95.66% | 5.23 B USD | ||
| 1329 |  CELC Celcuity Inc. - Common Stock | 103.79 USD | -3.52% | -6.02% | +15.36% | +649.39% | 5.06 B USD | ||
| 1372 |  LEGN Legend Biotech Corporation - American Depositary Shares | 25.75 USD | -4.91% | -8.72% | -27.51% | -19.48% | 4.76 B USD | ||
| 1374 |  DFTX Definium Therapeutics, Inc. - Common Shares | 43.65 USD | -7.27% | -1.58% | +76.22% | +188.88% | 4.76 B USD |
Frequently asked questions about CRISPR Therapeutics AG - Common Shares
What is the CRISPR Therapeutics AG - Common Shares stock price today?
The current price of CRISPR Therapeutics AG - Common Shares (CRSP) is 50.63. Over the past 24 hours, the stock has changed by -5.10%. Follow the CRSP chart for real-time price dynamics.
What is the stock ticker of CRISPR Therapeutics AG - Common Shares?
CRISPR Therapeutics AG - Common Shares trades under the ticker CRSP. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is CRISPR Therapeutics AG - Common Shares stock going up?
CRSP has changed by -18.52% over the last week, -0.73% over the last month, and -10.23% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was CRISPR Therapeutics AG - Common Shares net income for the last quarter?
CRISPR Therapeutics AG - Common Shares reported net income of -122.93 M for the last quarter. The previous quarter showed -130.61 M, which means net income changed by +5.88%.
How many employees does CRISPR Therapeutics AG - Common Shares have?
As of the latest available data, CRISPR Therapeutics AG - Common Shares has 393 employees. Workforce size can provide additional context about the company's scale and operations.
What is CRISPR Therapeutics AG - Common Shares EBITDA?
CRISPR Therapeutics AG - Common Shares EBITDA is -125.93 M, and its EBITDA margin is -8 637.11%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy CRISPR Therapeutics AG - Common Shares stock?
You can buy CRISPR Therapeutics AG - Common Shares (CRSP) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in CRISPR Therapeutics AG - Common Shares stock?
Investing in CRISPR Therapeutics AG - Common Shares requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the CRSP chart and related analysis on metatrader.com as part of your research.